LATEST NEWS
- Immune Matters
As I write this, several promising vaccine candidates are advancing through clinical trials. This pandemic will end through the development of vaccines, better treatments for people who are ill, and responsible social behavior.
- Institute News
New funding from the National Cancer Institute will let scientists get “whole picture” of the immune response
- Research News
Scientists in the U.S. and U.K. publish first in-depth look at how CD4+ T cells fight SARS-CoV-2
- Research News
COVID-carrying skiers may help explain disease trends in Germany
- Research News
LJI scientists track down a protein that may add to lung damage in asthma and related diseases
- Research News
Finding may help explain why people 65 and above face a higher risk of falling critically ill with COVID-19
- Institute News
More than 930,000 Americans are living with Parkinson's disease
- Research News
LJI and Scripps Research scientists tackle the problem of antigen valency
- Research News
New LJI discovery could help explain patterns of cell death in many autoimmune diseases
- Institute News
The National Institute of Allergy and Infectious Diseases (NIAID) has awarded more than $6.4 million to Dr. Saphire to support research toward COVID-19 antibody therapeutics.
- Research News
New understanding of immune cell origins may offer cancer and COVID-19 drug targets
